Pharmaceutical Intermediate Powder Peptide Bivalirudin Trifluoroacetate for Myocardial Infarction

Polypeptide Hormones Bivalirudin Trifluoroacetate Bivalirudin for Inhibiting Thrombin-Mediated

whatsapp:+8617707569722
web: http://www.roidraw.com
email: lucy@wumeitech.com20_副本

 

98% Injectable Polypeptide Hormones Bivalirudin Inhibiting Thrombin

Injectable Polypeptide Hormones Bivalirudin Trifluoroacetate CAS 128270-60-0

Hot Selling Medicine Grade Peptide Bivalirudin Trifluoroacetate CAS: 128270-60-0

Lab Supply Amino Acid Bivalirudin Trifluoroacetate /128270-60-0

Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).

Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).

Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI.

Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).

Bivalirudin Trifluoroacetate

Sequence:D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH

Alias:126:PN:WO2004076484PAGE:31 claimed protein;Angiomax;BG 8967;Bivalirudin;Hirulog; Hirulog

Bivalirudin Cas No.: 128270-60-0

Bivalirudin Molecular Formula: C98H138N24O33

Bivalirudin Molecular Weight: 2180.29

Bivalirudin Purity (HPLC): 98.0%min.

Bivalirudin Appearance: White Powder

Bivalirudin Single Impurity (HPLC): 1.0%max

Bivalirudin Amino Acid Composition: ±10% of theoretical

Bivalirudin Peptide Content (N%): >80.0%

Bivalirudin Water Content (Karl Fischer): <8.0% Bivalirudin TrifluoroAcetate Content(HPIC): >12.0%

Bivalirudin MS (ESI): Consistent

Bivalirudin Mass Balance: 95.0~105.0%

Bivalirudin Grade : Pharmaceutical Grade

Bivalirudin Storage: Closed, below 2 ~ 8ºC preservation

Delivery time : within 18 hours upon receipt of payment

Delivery: EMS, DHL, TNT, FedEx, UPS

Production Capacity: 10000vials

Transport Package:Alumiuim Foil or as Customer′s Requirement

Payment Terms:T/T, Western Union, Paypal, Money Gram, escrow,bank transfer

Bivalirudin Usage : This product is mainly used for the prevention of vascular forming interventional therapy in the treatment of unstable angina, ischemic complications before and after.

It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation.

Bivalirudin Description:

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).

Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin.

Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.

It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life.

It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response.

There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).

It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics make bivalirudin an ideal alternative to heparin.

Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials.

Customer Feedback:

Yes,i have recieved it,really fast,good job,thanks.

—–Jean from France

High quality. I have used your powders,I’m satisfied with the result I gained ! I am definitely looking for buying from you again !

— Joe

I have received 500g Tren Ace from your company. It’s very clear and strong. no pain when injection!Going to buy more!

— Bryan

I have received my products, you packing is do discreet and perfect, it really amazed me. I will order more from you as soon as possible. Thanks a lot.

————–Robet–Australia

I have cooperated with you for many times, your product quality is so great, that is why I still buy the products from you. Thank you

———–Richard—American

Hi lucy, your best price and high purity product is so competitive in my country, this let me make much profit, my customers are really like it. Cooperate with you is so wonderful! Thak you

————–Johnson—Canada

Advantage:

1, High quality with competitive price

1) Standard:BP/USP/EP/Enterprise standard

2) All Purity≥99%

3) We are manufacturer and can provide high quality products with factory price.

2, Fast and safe delivery

1) Parcel can be sent out in 24 hours after payment.Tracking number available

2) Secure and discreet shipment.Various transportation methods for your choice.

3) Customs pass rate ≥99%

4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,and we have stock in there for transferring.

3,We have clients throughout the world

1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.

2) Market feedback and goods feedback will be appreciated, meeting customers’s requirement is our responsibility.

3) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers

4,Great after-sales service we provide

Any questions or problems after receiving the product, please feel free to contact us.Problems would be solved immediately.

Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin.

Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation.

Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells.

Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).

It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.

Bivalirudin Function:

Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).

Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).

Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI. Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.

whatsapp:+8617707569722
web: http://www.roidraw.com
email: lucy@wumeitech.com